Alzheimer's Association Calls On CMS to Reverse Its Decision to Severely Limit Access To FDA-Approved Alzheimer's Disease Treatments
December 22, 2022
December 22, 2022
CHICAGO, Illinois, Dec. 22 (TNStalk) -- The Alzheimer's Association issued the following news release and letter:
The Alzheimer's Association filed a formal request asking the Centers for Medicare & Medicaid Services (CMS) to provide full and unrestricted coverage for Food and Drug Administration (FDA)-approved Alzheimer's treatments. In its letter, the Association asked CMS to remove the requirements for Coverage with Evidence Development (CED) in its national co . . .
The Alzheimer's Association filed a formal request asking the Centers for Medicare & Medicaid Services (CMS) to provide full and unrestricted coverage for Food and Drug Administration (FDA)-approved Alzheimer's treatments. In its letter, the Association asked CMS to remove the requirements for Coverage with Evidence Development (CED) in its national co . . .